News for 'Sun Pharma'

Sensex sheds 109 points at close; metal, bank stocks major drag

Sensex sheds 109 points at close; metal, bank stocks major drag

Rediff.com25 Jul 2024

Nestle, Titan, ICICI Bank, Tata Steel, IndusInd Bank, ITC, JSW Steel and State Bank of India were the other laggards. Among the gainers, Tata Motors jumped nearly 6 per cent. Larsen & Toubro, Sun Pharma, Kotak Mahindra Bank, Bajaj Finance and Power Grid also ended in the positive territory.

Future Gaming tops electoral bonds list with Rs 1368 cr; who are the others?

Future Gaming tops electoral bonds list with Rs 1368 cr; who are the others?

Rediff.com14 Mar 2024

These are the top buyers of the scrapped electoral bonds, the data for which was released by the Election Commission on Thursday.

India Inc feels the heat of West Asia conflict

India Inc feels the heat of West Asia conflict

Rediff.com29 Apr 2024

Closely watched by the world for any escalation, the Iran-Israel conflict is already showing early signs of stress for India Inc - longer deliveries, doubling freight rates, extended working capital cycles, and higher costs. For those yet to feel the heat, there is growing apprehension and nervousness over future developments, observed industry executives.

Indian pharma exports report double-digit growth after 3 yrs

Indian pharma exports report double-digit growth after 3 yrs

Rediff.com3 May 2019

The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.

IT & pharma stocks on funds' radars after fall

IT & pharma stocks on funds' radars after fall

Rediff.com8 Dec 2016

This is a shift as until recent months, fund managers were reducing exposure to these sectors.

Markets pare all gains; BSE, NSE end in red

Markets pare all gains; BSE, NSE end in red

Rediff.com11 Jul 2024

Among Sensex shares, Bajaj Finance, Mahindra & Mahindra, Sun Pharma, Nestle, NTPC, Power Grid, NTPC, UltraTech Cement and Larsen & Toubro were the biggest laggards. The prominent gainers were ITC, Tata Motors, Asian Paints and Titan.

Sensex, Nifty settle at new all-time highs

Sensex, Nifty settle at new all-time highs

Rediff.com26 Jun 2024

Among the 30 Sensex companies, Reliance Industries, Bharti Airtel, UltraTech Cement, Sun Pharma, Adani Ports, Axis Bank, NTPC and Bajaj Finance were the biggest gainers. Mahindra & Mahindra, Tata Steel, Tech Mahindra and JSW Steel were among the laggards.

2024's 10 Best Web Series

2024's 10 Best Web Series

Rediff.com9 Dec 2024

The year was rich in content as far as Web series were concerned.

Pandemic brings windfall for e-pharma companies

Pandemic brings windfall for e-pharma companies

Rediff.com27 Aug 2020

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022.

Sensex, Nifty tank nearly 1%; HDFC Bank drags

Sensex, Nifty tank nearly 1%; HDFC Bank drags

Rediff.com13 Aug 2024

Equity benchmark BSE Sensex tumbled nearly 700 points to sink below the 79,000 level on Tuesday, extending its losses for the second straight day due to selling pressure in HDFC Bank, SBI and ITC amid fresh foreign capital outflows. The 30-share BSE Sensex tumbled 692.89 points or 0.87 per cent to settle at 78,956.03. During the day, it tanked 759.54 points or 0.95 per cent to 78,889.38.

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

Trump's 'America First' agenda may lead to higher tariffs

Trump's 'America First' agenda may lead to higher tariffs

Rediff.com6 Nov 2024

With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue the 'America First' agenda, opined trade experts. Experts also said that Trump could also tighten H-1B visa rules, impacting costs and growth for Indian IT firms. Over 80 per cent of India's IT export earnings come from the US, making it vulnerable to changes in visa policies.

USFDA warns Aurobindo Pharma

USFDA warns Aurobindo Pharma

Rediff.com23 May 2011

Company had earlier received an import alert in February this year from the US Food and Drug Administration.

Sensex scales fresh high on buying in RIL, ICICI Bank and HDFC Bank

Sensex scales fresh high on buying in RIL, ICICI Bank and HDFC Bank

Rediff.com20 Jun 2024

Among the 30 Sensex companies, JSW Steel, Tata Steel, Axis Bank, Reliance Industries, ICICI Bank, Hindustan Unilever, Kotak Mahindra Bank and Asian Paints were among the biggest gainers. In contrast, Mahindra & Mahindra, Sun Pharma, NTPC, Wipro, State Bank of India and Power Grid were among the laggards.

Sensex, Nifty settle flat after hitting fresh all-time highs

Sensex, Nifty settle flat after hitting fresh all-time highs

Rediff.com29 Jul 2024

From the Sensex pack, Larsen & Toubro, Bajaj Finserv, Mahindra & Mahindra, UltraTech Cement, State Bank of India, IndusInd Bank, Reliance Industries and Sun Pharma were among the biggest gainers. Bharti Airtel, Titan, ITC, Kotak Mahindra Bank, Tech Mahindra and HDFC Bank were among the laggards.

Why 38% of IIT Graduates Are Unemployed

Why 38% of IIT Graduates Are Unemployed

Rediff.com28 Nov 2024

Out of 24,230 IIT and NIT grads, about 8,000 students didn't find any takers during campus placement drives this year.

Engineer arrested for post on bomb threat at Ambani wedding

Engineer arrested for post on bomb threat at Ambani wedding

Rediff.com16 Jul 2024

The Mumbai police were on high alert after an X user @ffsfir wrote a post about the potential threat which reads like "My mind is wondering shamelessly that half the world would go upside down tomorrow after a bomb went off at the Ambani wedding. trillions of dollars in one pin code."

Investors become poorer by Rs 9.51 lakh cr as markets crash

Investors become poorer by Rs 9.51 lakh cr as markets crash

Rediff.com5 Aug 2024

Investors' wealth eroded by Rs 9.51 lakh crore on Monday morning, following a crash in equity markets where the benchmark Sensex tanked over 2,400 points, mirroring a sharp plunge in global peers. The 30-share BSE benchmark tanked 2,401.49 points to 78,580.46 in early trade. Following the sharp decline in equities, the market capitalisation of BSE-listed firms dropped by Rs 9,51,771.37 crore to Rs 4,47,65,174.76 crore ($5.35 trillion) during the morning trade.

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

Sun Pharma acquires US-based Pharmalucence

Sun Pharma acquires US-based Pharmalucence

Rediff.com16 Jul 2014

Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Markets fall on selling in banking shares, STT hike

Markets fall on selling in banking shares, STT hike

Rediff.com24 Jul 2024

Benchmark BSE Sensex declined for the fourth day in a row on Wednesday due to selling in financial and banking shares and the government's move to hike securities transaction tax and short term capital gains tax. The 30-share BSE Sensex declined 280.16 points or 0.35 per cent to settle at 80,148.88 with 19 of its components closing lower and 11 with gains. During the day, it tumbled 678.53 points or 0.84 per cent to 79,750.51.

India's exports marginally up; trade deficit narrows

India's exports marginally up; trade deficit narrows

Rediff.com16 Oct 2024

Snapping the two months slide, the country's merchandise exports rose marginally by 0.5 per cent to $34.58 billion in September while trade deficit narrowed to $20.78 billion. According to official data released on Wednesday, imports increased by 1.6 per cent to $55.36 billion in September compared to $54.49 billion in the year-ago period. The trade deficit, or the gap between imports and exports, was $20.8 billion during the same month last year.

Goodbye Skipper!

Goodbye Skipper!

Rediff.com29 Nov 2024

'He asserted in his usual jovial style that he was not an MBA like his audience at IIM-Ahmedabad but perhaps had an even better business degree: MBB'. 'He went on to explain to his perplexed, blue chip B-School audience that MBB stood for "Marwadi by birth"!' Shivanand Kanavi salutes Shashi Ruia, co-founder of the Essar group who passed into the ages on November 25, 2024 in Mumbai.

Sensex climbs 305 points on buyingi in index heavyweights

Sensex climbs 305 points on buyingi in index heavyweights

Rediff.com27 Feb 2024

Among the Sensex firms, Tata Motors, Tata Consultancy Services, IndusInd Bank, Power Grid, Bharti Airtel, Sun Pharma, JSW Steel and Tata Steel were the major gainers. On the other hand, Bajaj Finance, State Bank of India, Bajaj Finserv, Axis Bank and NTPC were among the laggards.

Modi 3.0's Plans For Ayushman Bharat

Modi 3.0's Plans For Ayushman Bharat

Rediff.com12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat scheme to Rs 10 lakh from the current Rs 5 lakh.

Trump 2.0: Will Bulls Run Amok?

Trump 2.0: Will Bulls Run Amok?

Rediff.com8 Nov 2024

'Investors looking at the next 6-12 months can be certain that the Fed will maintain its easing cycle, and we expect the overall environment to be conducive for fixed income investments for portfolio diversification.'

Indian pharma's Trump fears

Indian pharma's Trump fears

Rediff.com1 Feb 2017

Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.

IT, banking shares help Sensex gain 443 points at close

IT, banking shares help Sensex gain 443 points at close

Rediff.com1 Jul 2024

Benchmark Sensex rose by 443 points to close at a new record high while Nifty settled above the 24,100 mark on Monday on buying in banking and IT shares in line with gains in Asian and European markets. The 30-share BSE Sensex settled higher by 443.46 points or 0.56 per cent at an all-time high of 79,476.19.

After showing signs of recovery, pharma sales dip in July

After showing signs of recovery, pharma sales dip in July

Rediff.com11 Aug 2020

Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed.

Why Japan is betting big on Indian pharma cos

Why Japan is betting big on Indian pharma cos

Rediff.com26 Jan 2017

One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions.

Trade generics growth to dent value expansion of domestic drug market

Trade generics growth to dent value expansion of domestic drug market

Rediff.com2 Jan 2024

Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. According to a Kotak Institutional Equities analysis, 70-110 basis points (bps) annual dent is expected from trade generics and Jan Aushadhi on Indian Pharma Market (IPM) growth at least until FY27-28 (see chart). Trade generic medicines are those that are not pushed into the market through doctor promotions.

Regulatory woes torpedo PE/VC deals in e-pharma sector

Regulatory woes torpedo PE/VC deals in e-pharma sector

Rediff.com27 Jun 2023

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture capitalists (VCs). The data from Venture Intelligence shows so far in 2023 (as of June 13) there has been one deal with PE-VC funding. In 2022 there were four, a sharp fall from the 12, totalling $1,520 million, the sector had attracted in 2021.

Sensex pares losses, ends 131 points higher

Sensex pares losses, ends 131 points higher

Rediff.com24 Jun 2024

Among the 30 Sensex companies, Mahindra & Mahindra, Power Grid, Sun Pharma, Nestle, UltraTech Cement, NTPC, ITC, ICICI Bank, Titan, Bajaj Finserv, Bharti Airtel, and HDFC Bank were among the biggest gainers. IndusInd Bank, Adani Ports, Tata Steel, Reliance Industries, Axis Bank and Bajaj Finance were among the laggards.

Pharma stocks on a booster dose

Pharma stocks on a booster dose

Rediff.com1 Mar 2014

Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally

Export plunges 9.3%; trade deficit widens to 10-month high

Export plunges 9.3%; trade deficit widens to 10-month high

Rediff.com17 Sep 2024

India's exports registered a steepest decline in 13-month falling 9.3 per cent in August to $34.71 billion due to global economic uncertainties, while the trade deficit soared to a 10-month of $29.65 billion. According to the government data released on Tuesday, imports increased by 3.3 per cent to $64.36 billion, which is a record high, due to a significant jump in the inbound shipments of gold and silver.

Daiichi Sankyo to offload stake in Sun Pharma

Daiichi Sankyo to offload stake in Sun Pharma

Rediff.com20 Apr 2015

Daiichi won't remain a major shareholder in Sun Pharma.

Sensex regains 75K-mark; Nifty gains 201 points

Sensex regains 75K-mark; Nifty gains 201 points

Rediff.com6 Jun 2024

Among the 30 Sensex companies, Tech Mahindra, HCL Technologies, State Bank of India, NTPC, Infosys, Larsen & Toubro, Tata Consultancy Services and Wipro emerged as the biggest gainers. Hindustan Unilever, Asian Paints, Mahindra & Mahindra, Nestle, IndusInd Bank and Sun Pharma were among the laggards.

Centre bans 156 drugs used for fever, pain, allergies

Centre bans 156 drugs used for fever, pain, allergies

Rediff.com22 Aug 2024

FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also referred to as 'cocktail' drugs.

Why Is USFDA Inspecting India Pharma Firms?

Why Is USFDA Inspecting India Pharma Firms?

Rediff.com30 Dec 2022

Indian drug firms continue to work closely with the FDA, and most have also appointed consultants to help them grasp the regulatory minutiae in the US.

Who Are India's Newest Billionaires?

Who Are India's Newest Billionaires?

Rediff.com11 Oct 2024

The collective wealth of the 100 richest went past $1 trillion for the first time.